PHAXIAM Therapeutics SA ADR (PHXM) Income Statement (2016 - 2023)
Income Statement report data from Jun 30, 2016 to Dec 31, 2023 for PHAXIAM Therapeutics SA ADR (PHXM) in EUR with ability to convert in USD.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Jun 30, 2017 | Dec 31, 2016 | Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||||
Cost Of Revenue | 470K | - | - | - | 1.67M | - | 4.29M (+48.44%) | 2.89M | - | - | 2.49M (-76.31%) | 11M (+323.79%) | 2.48M | - | 2.44M | - | 15M (+6.73%) | 14M (+1196.36%) | 1.10M | - | 7.74M (-13.71%) | 8.97M (+1850.00%) | 460K (+70.37%) | 270K (+3.85%) | 260K (+73.33%) | 150K (-44.44%) | 270K |
Costof Goods And Services Sold | 470K | - | - | - | 1.67M | - | 4.29M (+48.44%) | 2.89M | - | - | 2.49M (-76.31%) | 11M (+323.79%) | 2.48M | - | 2.44M | - | 15M (+6.73%) | 14M (+1196.36%) | 1.10M | - | 7.74M (-13.71%) | 8.97M (+1850.00%) | 460K (+70.37%) | 270K (+3.85%) | 260K (+73.33%) | 150K (-44.44%) | 270K |
Gross Profit | -470.00K | - | - | - | -1.67M | - | - | - | - | - | - | -10.51M | - | - | - | - | -15.22M (+6.73%) | -14.26M | - | - | -340.00K (-96.21%) | -8.97M (+1850.00%) | -460.00K (+70.37%) | -270.00K (+3.85%) | -260.00K (+73.33%) | -150.00K (-44.44%) | -270.00K |
Operating Expenses | |||||||||||||||||||||||||||
Research And Development | 7.01M (+110.51%) | 3.33M | - | - | 470K (-84.74%) | 3.08M (-66.45%) | 9.18M (+13.05%) | 8.12M (-21.70%) | 10M (-9.98%) | 12M (-9.29%) | 13M (+20.84%) | 11M (-28.21%) | 15M (+3.83%) | 14M (+4.44%) | 14M (-12.05%) | 15M (+0.85%) | 15M (+6.73%) | 14M (+5.24%) | 14M (+47.76%) | 9.17M (+18.48%) | 7.74M (-13.71%) | 8.97M (-46.35%) | 17M (+26.28%) | 13M (+10.70%) | 12M (+10.03%) | 11M (+25.37%) | 8.67M |
Selling General And Administrative | - | 2.96M | - | - | 1.34M (-64.74%) | 3.80M (+77.57%) | 2.14M (-56.68%) | 4.94M (+72.73%) | 2.86M (-37.14%) | 4.55M (+29.26%) | 3.52M (-15.59%) | 4.17M (+46.83%) | 2.84M (-16.96%) | 3.42M (-3.39%) | 3.54M (-21.16%) | 4.49M (+11.97%) | 4.01M (-2.43%) | 4.11M (-14.20%) | 4.79M (-1.24%) | 4.85M (+8.50%) | 4.47M (+45.13%) | 3.08M | - | - | - | - | - |
Operating Expenses | 12M (+105.56%) | 5.76M | - | - | -2.68M | 5.57M (-52.56%) | 12M (-6.23%) | 13M (-3.32%) | 13M (-11.30%) | 15M (-7.12%) | 16M (+18.64%) | 13M (-23.54%) | 17M (+7.44%) | 16M (-0.92%) | 16M (-14.72%) | 19M (-42.20%) | 33M (+1311.54%) | 2.34M (-86.22%) | 17M (+28.05%) | 13M (+32.73%) | 9.99M (-14.98%) | 12M (-50.40%) | 24M (+31.54%) | 18M (+14.57%) | 16M (+16.44%) | 14M (+5.88%) | 13M |
Depreciation And Amortization | 470K (+80.77%) | 260K (+116.67%) | 120K | - | 1.67M (-73.37%) | 6.27M (+46.15%) | 4.29M | -1.17M (+148.94%) | -470.00K | 2.66M (+6.83%) | 2.49M (+21.46%) | 2.05M (-17.34%) | 2.48M | -70.00K | 2.44M (+50.62%) | 1.62M (-26.70%) | 2.21M (+142.86%) | 910K | -420.00K | 1.66M (+876.47%) | 170K (0.00%) | 170K (-63.04%) | 460K (+70.37%) | 270K (+3.85%) | 260K (+73.33%) | 150K (-44.44%) | 270K |
Operating Income | |||||||||||||||||||||||||||
Operating Income | -12.31M (+114.09%) | -5.75M | - | - | 2.68M | -5.57M | 13M | -12.51M (-4.87%) | -13.15M (-8.68%) | -14.40M (-8.40%) | -15.72M (+18.73%) | -13.24M (-23.60%) | -17.33M (+7.44%) | -16.13M (-0.92%) | -16.28M (-14.72%) | -19.09M (+10.80%) | -17.23M (+3.86%) | -16.59M (-2.30%) | -16.98M (+28.05%) | -13.26M (+32.73%) | -9.99M (-14.98%) | -11.75M (-51.33%) | -24.14M (+32.06%) | -18.28M (+14.39%) | -15.98M (+17.07%) | -13.65M (+4.84%) | -13.02M |
Ebit | -12.31M (+114.09%) | -5.75M (+28.06%) | -4.49M (0.00%) | -4.49M (-47.67%) | -8.58M (+9.72%) | -7.82M | 10M | -12.44M (-5.40%) | -13.15M (-8.68%) | -14.40M (-20.04%) | -18.01M (+36.03%) | -13.24M (-41.65%) | -22.69M (+40.67%) | -16.13M (-18.12%) | -19.70M (+3.20%) | -19.09M (-6.74%) | -20.47M (+38.59%) | -14.77M (-13.02%) | -16.98M (+28.05%) | -13.26M (+54.73%) | -8.57M (-19.83%) | -10.69M (-55.72%) | -24.14M (+32.06%) | -18.28M (+14.39%) | -15.98M (+17.07%) | -13.65M (+4.84%) | -13.02M |
EBITDA | -11.84M (+115.66%) | -5.49M | - | - | -6.92M (+343.59%) | -1.56M | 15M | -11.67M (-14.32%) | -13.62M (+16.01%) | -11.74M (-24.36%) | -15.52M (+38.57%) | -11.20M (-44.58%) | -20.21M (+24.75%) | -16.20M (-6.14%) | -17.26M (-1.20%) | -17.47M (-4.33%) | -18.26M (+31.75%) | -13.86M (-20.34%) | -17.40M (+50.00%) | -11.60M (+38.10%) | -8.40M (-20.15%) | -10.52M (-55.59%) | -23.69M (+31.54%) | -18.01M (+14.57%) | -15.72M (+16.44%) | -13.50M (+5.88%) | -12.75M |
Other Income / Expenses | |||||||||||||||||||||||||||
Interest Income | - | 290K | - | - | 420K (-89.58%) | 4.03M (+379.76%) | 840K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense | 90K (-70.97%) | 310K | - | - | 480K (-21.31%) | 610K (+125.93%) | 270K (+12.50%) | 240K (-73.63%) | 910K (-32.09%) | 1.34M (-25.14%) | 1.79M (+138.67%) | 750K (-63.59%) | 2.06M (-13.81%) | 2.39M (+785.19%) | 270K (+125.00%) | 120K (-89.57%) | 1.15M (+945.45%) | 110K (-64.52%) | 310K (+416.67%) | 60K | - | - | 40K (-98.73%) | 3.14M (+6180.00%) | 50K (+25.00%) | 40K (+33.33%) | 30K |
Net Interest Income | - | -40.00K | - | - | -60.00K | 3.40M | -850.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | |||||||||||||||||||||||||||
Income Before Tax | -12.08M (+112.30%) | -5.69M | - | - | 2.62M | -5.04M | 15M | -11.91M (-0.83%) | -12.01M (-13.16%) | -13.83M (-13.56%) | -16.00M (+34.00%) | -11.94M (-39.54%) | -19.75M (+6.24%) | -18.59M (+7.02%) | -17.37M (-1.25%) | -17.59M (-9.33%) | -19.40M (+38.87%) | -13.97M (-20.72%) | -17.62M (+51.11%) | -11.66M (+36.06%) | -8.57M (-19.83%) | -10.69M (-49.58%) | -21.20M (+1.39%) | -20.91M (+32.26%) | -15.81M (+19.23%) | -13.26M (+9.23%) | -12.14M |
Income Tax Expense | -790.00K | - | -100.00K (0.00%) | -100.00K (-96.99%) | -3.32M | 100K (-97.33%) | 3.74M (+1770.00%) | 200K (0.00%) | 200K | -200.00K | - | - | - | - | - | - | - | - | - | - | - | -10.00K (-99.55%) | -2.23M (+52.74%) | -1.46M (-15.61%) | -1.73M (+8.81%) | -1.59M (-11.67%) | -1.80M |
Net Income From Continuing Operations | - | -5.69M | - | - | 5.93M | -5.14M | 11M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | -11.29M (+98.42%) | -5.69M | - | - | 5.94M | -5.14M | 11M | -11.91M (-2.46%) | -12.21M (-10.42%) | -13.63M (-14.87%) | -16.01M (+34.09%) | -11.94M (-39.54%) | -19.75M (+6.24%) | -18.59M (+7.02%) | -17.37M (-1.25%) | -17.59M (-9.33%) | -19.40M (+38.87%) | -13.97M (-20.72%) | -17.62M (+51.11%) | -11.66M (+36.06%) | -8.57M (-19.76%) | -10.68M (-43.70%) | -18.97M (-2.47%) | -19.45M (+38.14%) | -14.08M (+20.75%) | -11.66M (+12.66%) | -10.35M |